- Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
Upturn AI Summary - About
Envista Holdings Corp(NVST)
Advisory History & Simulated Performance *
*as per simulation (see disclosures)- ALL
- 1Y
- 1M
- 1W
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- PASS (Skip)
Advisory Performance History (Simulated)
Upturn Advisory & Investor View for NVST
11/13/2026: NVST (1-star) is currently NOT-A-BUY. Pass it for now.
Envista Holdings Corp is a pure-play dental device company that operates across two primary segments: dental equipment and specialty products. The company benefits from strong, recognizable brands such as Nobel Biocare and Ormco, and is focusing on expanding its digital dentistry portfolio to drive long-term growth. While the business has a leading position in niche areas, it faces significant risks from cyclical consumer spending and intense competition from major industry players. The stock may suit investors looking for exposure to the dental market, provided they are comfortable with volatility in elective care. Key developments for investors to monitor include margin improvement progress and the continued adoption of the Spark clear aligner platform.
How to Read the Upturn Advisory
The Upturn Star Rating and the current BUY, SELL, or PASS advisory are generated by Upturn’s AI advisory engine based on proprietary signal analysis, price behavior, advisory history, and historical signal performance.
Company fundamentals, valuation, risks, and news provide supporting context about the business.
Investor Fit
| Investor style | Fit | Why |
|---|---|---|
| Growth investor | Mixed fit | The company targets growth in dental technology, but results are often cyclical and dependent on consumer spending. |
| Momentum investor | Weak fit | The stock often lacks strong, consistent upward price momentum compared to high-growth tech or healthcare peers. |
| Value investor | Mixed fit | Valuation can be attractive depending on the cycle, but execution risks persist. |
| Dividend investor | Weak fit | The company does not pay a dividend. |
| Low-risk investor | Weak fit | Market volatility and exposure to consumer-driven elective procedures make it less suitable for risk-averse investors. |
Risk Profile
| Risk factor | Level | Why it matters |
|---|---|---|
| Price volatility | Medium / high | The stock is susceptible to fluctuations based on elective procedure trends. |
| Valuation risk | Medium | Market pricing depends heavily on sustained growth in digital dental segments. |
| Competition risk (dental devices) | High | Intense competition from entrenched players like Align and Dentsply limits pricing power. |
| Business quality | Medium | While the franchise has strong brands, historical margins have been inconsistent. |
| Dividend income | Low / none | Income investors will not find yield here. |
| Execution risk | Medium / high | Successful integration of acquired technologies remains critical for long-term growth. |
Key Highlights
Company Size Mid-Cap Stock | Market Capitalization 3.93B USD | Price to earnings Ratio 6.41 | 1Y Target Price 28.92 |
Price to earnings Ratio 6.41 | 1Y Target Price 28.92 | ||
Volume (30-day avg) 3.1M shares | Beta 0.94 | 52 Weeks Range 18.77 - 30.42 | Updated Date 11/14/2026 |
52 Weeks Range 18.77 - 30.42 | Updated Date 11/14/2026 | ||
Dividends yield (FY) - | Basic EPS (TTM) 3.82 |
Sector & Industry Intelligence
Sector
Healthcare
Bullish- Sentiment
- Strong Bullish
- Momentum
- Momentum Steady
- BUY participation
- 62.6%
- Active BUY / eligible
- 72 / 115
- 30-Day BUY Count Change
- +35
- Market state
- Strong Bullish
The number of qualifying BUY stocks has remained relatively stable.
Industry
Medical Instruments & Supplies
- BUY participation
- 60.0%
- Active BUY / eligible
- 3 / 5
- 30-Day BUY Count Change
- +1
Eligible universe: 5 stocks.
Sector signal summarizes BUY breadth conditions for the sector. It does not override this stock’s BUY, SELL, or PASS advisory.
Price Behavior

Downtrend
The stock has experienced a sustained decline in price over recent periods.

Moderately Choppy
The stock has experienced noticeable price swings while retaining some directional structure.
Analysis of Past Performance
Type Stock | Historic Profit -4.89% | Avg. Invested days 52 | Today’s Advisory PASS |
Upturn Advisory Rating ![]() | Upturn Advisory Performance | Stock Returns Performance |
Upturn Scorecard
Upturn Star Rating 
Company Fundamentals 
Financial Health Rating 
Growth Momentum Score 
Ownership 
Top 5 Institutional Investors
Unit Economics (Per $1K Revenue) 
Economic Dimensions
Quantitative Style Profile 
Style Classification
Quality Focused
How Company Makes Money
| Business area | What it includes | Retail investor read |
|---|---|---|
| Equipment and Consumables | Imaging hardware, restorative materials, and treatment units. | The company sells the core tools and materials dentists need for daily practice. |
| Specialty Products | Nobel Biocare implants and Ormco orthodontic solutions. | High-end, recurring-revenue products for specialized procedures like implants and orthodontics. |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Revenue by Geography
Geography revenue - Year on Year
Earnings Date
Report Date 2026-11-04 | When After Market | Estimate 0.35 | Actual 0.4 |
Profitability
Profit Margin 22.02% | Operating Margin (TTM) 10.59% |
Management Effectiveness
Return on Assets (TTM) 3.39% | Return on Equity (TTM) 20.52% |
Valuation
Trailing PE 6.41 | Forward PE 16.81 | Enterprise Value 4.38B | Price to Sales(TTM) 1.36 |
Enterprise Value 4.38B | Price to Sales(TTM) 1.36 | ||
Enterprise Value to Revenue 1.52 | Enterprise Value to EBITDA 5.06 | Shares Outstanding 160.34M | Shares Floating 159.55M |
Shares Outstanding 160.34M | Shares Floating 159.55M | ||
Percent Insiders 0.56 | Percent Institutions 120.47 |
Financial Metrics
🧭 Investment Snapshot
Total Revenue (Scale)
Total money earned from selling products or services before any costs. It is needed to understand the scale of the business and its ability to generate income.
Net Income (Profit)
Final profit after all expenses, interest, and taxes are deducted. It is needed to determine the overall profitability available to shareholders.
Free Cash Flow (Cash Strength)
Cash remaining after operating activities and capital expenditures, showing cash available for growth. It is needed to evaluate the company’s ability to invest, pay dividends, or reduce debt.
📈 Growth & Strength
Operating Income (Core Profit)
Profit from core operations after deducting all operating expenses. It is needed to measure how efficiently the company runs its primary business activities.
EBITDA (Cash Earnings)
Earnings before interest, taxes, depreciation, and amortization, indicating operating cash potential. It is needed to compare operating performance across companies without accounting or financing differences.
Gross Profit (Unit Profitability)
Revenue minus cost of revenue, showing profit after direct production costs. It is needed to evaluate core business profitability before overhead expenses.
🛡️ Financial Safety
Cash (Liquidity Buffer)
Total cash and cash equivalents on hand. It is needed to evaluate immediate liquidity and financial flexibility.
Total Debt (Leverage Risk)
Total debt including both short-term and long-term components. It is needed to assess the company’s leverage and financial risk.
Net Working Capital (Short-Term Health)
Current assets minus current liabilities, indicating short-term liquidity strength. It is needed to assess whether the company can meet its short-term obligations.
🧱 Balance Sheet Strength
Stockholder Equity (Net Worth)
Total equity value held by shareholders. It is needed to understand the net worth of the company from the owners’ perspective.
Total Assets (Asset Base)
The full value of everything the company owns, including cash, inventory, equipment, and investments. It is needed to understand the resource base used to generate revenue.
Income Before Tax (Pre-Tax Earnings)
Income before provision for income taxes. It is needed to analyze profitability independent of tax structures.
⚙️ Cost & Drag Factors
Cost of Revenue (Production Cost)
Direct costs required to produce and deliver the products or services sold. It is needed to assess efficiency in production and service delivery.
Total Operating Expenses (Operating Cost)
Indirect costs of running the business such as salaries, marketing, and administration. It is needed to understand how much it costs to sustain ongoing business operations.
Income Tax Expense (Tax Drag)
Amount of taxes paid or payable to the government. It is needed to evaluate the impact of taxation on overall profitability.

Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.
All company names, trademarks, logos, and brands are the property of their respective owners and are used for identification and informational purposes only. Use of these names, trademarks, and logos does not imply endorsement by their respective owners.

